About the Authors
- Shuai Wang
-
Contributed equally to this work with: Shuai Wang, Xun Huang
Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Xun Huang
-
Contributed equally to this work with: Shuai Wang, Xun Huang
Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Danni Sun
-
Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Xianliang Xin
-
Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Qiuming Pan
-
Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Shuying Peng
-
Affiliation Laboratory of Mass Spectrometry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Zhongjie Liang
-
Affiliation Center for Drug Discovery and Design, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Cheng Luo
-
Affiliation Center for Drug Discovery and Design, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Yiming Yang
-
Affiliation Laboratory of Mass Spectrometry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Hualiang Jiang
-
Affiliation Center for Drug Discovery and Design, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Min Huang
-
Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Wengang Chai
-
Affiliations Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China, Glycosciences Laboratory, Faculty of Medicine, Imperial College London, Harrow, United Kingdom
- Jian Ding
-
* E-mail: mygeng@mail.shcnc.ac.cn (MG); jding@mail.shcnc.ac.cn (JD)
Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Meiyu Geng
-
* E-mail: mygeng@mail.shcnc.ac.cn (MG); jding@mail.shcnc.ac.cn (JD)
Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: SW XH JD MG. Performed the experiments: SW XH DS QP SP ZL. Analyzed the data: SW XH DS XX MH WC JD MG CL YY HJ. Contributed reagents/materials/analysis tools: SW XH DS QP SP ZL. Wrote the paper: SW XH XX MH WC JD MG.